4//SEC Filing
Llorens Josep 4
Accession 0001127602-24-016169
CIK 0000313143other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 5:52 PM ET
Size
9.7 KB
Accession
0001127602-24-016169
Insider Transaction Report
Form 4
Llorens Josep
SVP, Global Manufacturing
Transactions
- Sale
Common Stock
2024-05-20$95.08/sh−987$93,844→ 21,310 total - Tax Payment
Common Stock
2024-05-17$95.73/sh−320$30,634→ 16,030 total - Award
Common Stock
2024-05-17+6,267→ 22,297 total - Sale
Common Stock
2024-05-17$94.82/sh−822$77,942→ 16,350 total
Footnotes (5)
- [F1]Transaction pursuant to an existing 10b5-1 trading plan dated August 28, 2023 (fully executed as of August 31, 2023).
- [F2]This number includes unvested restricted stock units ("RSUs") previously reported.
- [F3]Represents shares withheld for tax obligations in connection with the vesting of certain RSUs previously reported in Table I.
- [F4]The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.
- [F5]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001750812
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 5:52 PM ET
- Size
- 9.7 KB